TICH-2 TRIAL - TRANEXAMIC ACID FOR INTRACEREBRAL HAEMORRHAGE 2

被引：0
|
作者：
Sprigg, N. [1 ]
Bath, P. [1 ]
Appleton, J. [1 ]
Foster, H. [1 ]
Adrian, M. [1 ]
Stringer, M. [1 ]
Longmate, J. [1 ]
Keeling, J. [1 ]
Kirby, J. [1 ]
Smithson, J. [1 ]
Robson, K. [1 ]
Scutt, P. [1 ]
机构：
[1] Univ Nottingham, Stroke Div Clin Neurosci, Nottingham, England
来源：
INTERNATIONAL JOURNAL OF STROKE | 2016年 / 11卷 / SUPP 3期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
597
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [21] Clinical and radiological predictors of cognitive impairment after intracerebral haemorrhage at day 365: data from the Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) trial
    Belcher, A.
    Woodhouse, L.
    Bath, P. M.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (4_SUPPL) : 15 - 15
  • [22] EFFECT OF PRIOR ANTIPLATELET THERAPY ON HAEMATOMA CHARACTERISTICS AND FUNCTIONAL OUTCOME: A SUBGROUP ANALYSIS OF THE TRANEXAMIC ACID IN INTRACEREBRAL HAEMORRHAGE-2 (TICH-2) TRIAL
    Law, Z. K.
    Flaherty, K.
    Scutt, P.
    Appleton, J.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 4 - 5
  • [23] Patients From the Tranexamic Acid for Hyperacute Intracerebral Haemorrhage (TICH-2) Trial Suffering From Hyperglycaemia at Baseline; Their Characteristics and Day 90 Outcomes
    Sprigg, Nikola
    Robson, Katie
    Bath, Philip M.
    STROKE, 2016, 47
  • [24] Patients from the Tranexamic acid for hyperacute IntraCerebral Haemorrhage (TICH-2) trial suffering from hyperglycaemia at baseline: Their characteristics and day 90 outcomes
    Robson, K.
    Krishnan, K.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 15 - 15
  • [25] ANAEMIA AT BASELINE CAN PREDICT POOR FUNCTIONAL OUTCOME: DATA FROM THE ONGOING TRANEXAMIC ACID FOR HYPERACUTE PRIMARY INTRACEREBRAL HAEMORRHAGE (TICH-2) TRIAL
    Robson, K.
    Appleton, J.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 70 - 70
  • [26] Incidence, risk factors and outcomes of seizures in intracerebral haemorrhage: interim analysis from the TICH-2 trial
    Law, Z. K.
    Flaherty, K.
    Appleton, J. P.
    Scutt, P.
    England, T. J.
    Bath, P. M.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 : 48 - 48
  • [27] TRANEXAMIC ACID FOR PREVENTION OF HAEMATOMA EXPANSION IN INTRACEREBRAL HAEMORRHAGE PATIENTS WITH AND WITHOUT CT-ANGIOGRAPHY SPOT SIGN ON ADMISSION SCAN: A PRESPECIFIED TICH-2 TRIAL SUBSTUDY
    Ovesen, C.
    Jakobsen, J. C.
    Gluud, C.
    Steiner, T.
    Law, Z.
    Flaherty, K.
    Dineen, R. A.
    Bath, P. M.
    Sprigg, N.
    Christensen, H.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 28 - 28
  • [28] Tranexamic acid for acute intracerebral haemorrhage (TICH): Results of the first randomised controlled trial
    Sprigg, N.
    Renton, C.
    Kwong, Y.
    Dineen, R.
    Bath, P. M.
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 7 - 7
  • [29] DOES TRANEXAMIC ACID IMPROVE OUTCOME FOR PATIENTS WITH SURGICALLY TREATED INTRA-CEREBRAL HAEMORRHAGE? RESULTS FROM THE TRANEXAMIC ACID FOR INTRA-CEREBRAL HAEMORRHAGE-2 (TICH-2) TRIAL
    Hollingworth, M.
    Woodhouse, L.
    Law, Z.
    Krishnan, K.
    Dineen, R.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 112 - 112
  • [30] Baseline characteristics of patients enrolled in the tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH 2) study
    Robson, K.
    Sprigg, N.
    Krishnan, K.
    Bath, P.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 14 - 14
12345